Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sochinaz is a Swiss-based Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs). Founded in 1954 and located in Vionnaz, the company focuses on complex small molecule synthesis, including high potency APIs (HPAPIs) and controlled substances. Sochinaz provides services ranging from process research and development to pilot-scale and full commercial-scale GMP manufacturing. Since 2016, it has operated as a subsidiary of the Rivopharm group, leveraging its expertise in organic chemistry to support global pharmaceutical and biotech partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sochinaz.